Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test
Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators.
TL;DR
- Moderna shares more than doubled on Wednesday.
- The company announced initial results from an experimental cancer treatment study.
- The treatment could be the first of its kind if approved.